GoodRx Holdings, Inc. Class A GDRX 深 沪
已收盘 01-30 16:00:00 美东时间
2.27
-0.130
-5.42%
华盛通- 最 高2.385
- 今 开2.36
- 成交量 255.39万股
- 最 低 2.24
- 昨 收 2.40
- 总市值 7.70亿
- 52周最高 5.8099
- 市盈率 静 54.31
- 换手率 0.75%
- 52周最低 2.24
- 委 比 40.71%
- 总股本 3.39亿
- 历史最高 64.219
- 量 比 0.89
- 振 幅 6.04%
- 历史最低 2.24
- 每 手 1
- 风险率 0.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews
Analysts' ratings for GoodRx Holdings (NASDAQ:GDRX) over the last quarter vary ...
01-23 06:01
Jefferies Downgrades GoodRx Holdings to Hold, Lowers Price Target to $2.75
Jefferies analyst Glen Santangelo downgrades GoodRx Holdings (NASDAQ:GDRX) from Buy to Hold and lowers the price target from $5.25 to $2.75.
01-22 21:12
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencora, Crocs and Teledyne Technologies, on Thursday. HIGHLIGHTS * Cencora COR.N : Jefferies raises to b
01-22 15:17
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $4.5
Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers the price target from $5 to $4.5.
01-09 23:59
GoodRx, LifeMD gain on offerings for Novo’s Wegovy pill
Shares of LifeMD (LFMD) and GoodRx (GDRX) traded higher in the premarket on Monday after the companies announced the availability of Novo Nordisk’s (NVO) Wegovy pill as part of their product offerings...
01-05 21:48
快讯 | GoodRx现在提供诺和诺德公司Wegovy®药片上市的现金价格。
GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill
01-05 21:05
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
Morgan Stanley Maintains Equal-Weight on GoodRx Holdings, Lowers Price Target to $4
Morgan Stanley analyst Craig Hettenbach maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weight and lowers the price target from $5 to $4.
2025-12-19 01:56
